PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth Mar 03, 2022 8:25am EST
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors Feb 15, 2022 8:25am EST
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference Feb 10, 2022 8:25am EST
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference Jan 06, 2022 8:30am EST
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth Dec 01, 2021 8:30am EST
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results Nov 16, 2021 4:13pm EST
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers Nov 11, 2021 8:30am EST
